Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 976 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Cauliflower Rice August 28, 2020 Waiting for Insurance to Cover Her Mammogram Could Have Cost This... April 9, 2019 Tattoo Artist Offers Free Nipple Tattoos To Breast Cancer Patients That... March 19, 2020 Trastuzumab Deruxtecan Shows Durable Anticancer Activity in Patients with Previously Treated... January 28, 2022 Load more HOT NEWS As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s... Mylan Recalls Injectable Cancer Drug After Particulates Discovered Expression of AR-regulated Genes in CTCs Is Prognostic for Survival and... Targeted Therapy for Claudin-18.2 and Combined PD-1 and TIGIT Immunotherapy for...
